Gastric Cancer Genetics and Its Implications for Diagnosis, Prognosis, and Treatment of the Disease

Data de publicação:

Autores da FMUP

  • Janete Maria Quelhas Dos Santos

    Autor

  • Joana Pinto De Figueiredo

    Autor

  • José Carlos Lemos Machado

    Autor

Unidades de investigação

Abstract

<jats:p>Gastric cancer (GC) is an aggressive disease and the fifth most common cancer worldwide with a variable geographical distribution. GC has a very low survival rate, mainly because of its heterogeneous presentation, multifactorial etiology, and late diagnosis. It is well established that various risk factors contribute to the development of the disease, including salty diet, smoking, and excessive alcohol consumption. Importantly, interactions between genetic and environmental traits trigger the activation of key signaling pathways, influencing gastric cell behavior towards neoplastic transformation and progression. Despite important advances in our understanding of GC, it remains a major health burden owing to epidemiological and therapeutic limitations. This study aimed to provide a comprehensive overview of the genetic landscape of GC phenotypes and molecular biomarkers for diagnosis and prognosis. In particular, we discuss the advances in genomic knowledge and technology that have yielded comprehensive information on the genetics of GC and classified it from a histological to a molecular perspective. Therefore, targeted and immune-based therapies have been developed, highlighting the challenges associated with intratumoral and interpatient heterogeneity. Finally, we explored potential research avenues on the intricacies of GC and identified accurate biomarkers for improved cancer screening and stratification. The development of innovative approaches to tackle relevant molecules is needed for GC management.</jats:p>

Dados da publicação

ISSN/ISSNe:
1738-3331,

The Korean Journal Of Helicobacter And Upper Gastrointestinal Research  

Tipo:
Article
Páginas:
103-

Documentos

  • Não há documentos

Métricas

Filiações

Filiações não disponíveis

Proyectos asociados

A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation (ZEUS) - NCT05021835

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Ensaio Clínico Comercial (ZEUS) . Novo Nordisk . 2022

Citar a publicação

Partilhar a publicação